FeatureAdjunct to Improve Postprandial Hyperglycaemia in Patients with Type-2 Diabetes
GradeMedicine Grade
Best Before24 months from Manufacture date
Type of MedicineAllopathic
Form Of MedicineTablets
Details :
More potent and tolerant a glycosisade inhibitor as compared to Acarbose and Miglitol
Delays absorption and digestion of dietary polysaccharides by reversibly inhibiting carbohydrate digestive enzymes thus results in reduction in Post-Prandial Hyperglycaemia
Significantly reduces HbA1 c and Post-Prandial blood glucose
Useful in elderly patients and in those with hepatic impairment or mild to moderate renal function impairments when other anti diabetic agents are contraindicated